Pricing
  1. JP-listed companies
  2. Euglena Co., Ltd.
  3. Financials
  4. Gross profit

Euglena Co., Ltd. (2931)

Market cap
¥57.8B
P/E ratio
Develops health foods, cosmetics, and biofuels using Euglena microalgae through proprietary large-scale cultivation technology across healthcare and sustainable energy markets.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndGross profit (Million JPY)YoY (%)
Dec 31, 202535,033+5.31%
Dec 31, 202433,267+4.70%
Dec 31, 202331,774+2.51%
Dec 31, 202230,996+44.37%
Dec 31, 202121,469+43.10%
Sep 30, 202115,003+58.06%
Sep 30, 20209,492-4.67%
Sep 30, 20199,958-9.10%
Sep 30, 201810,954+7.30%
Sep 30, 201710,209+25.47%
Sep 30, 20168,137+102.44%
Sep 30, 20154,019+117.42%
Sep 30, 20141,849

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat